uric acid has been researched along with Hyperoxaluria in 68 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Hyperoxaluria: Excretion of an excessive amount of OXALATES in the urine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "75 percent ethylene glycol (v/v) in their drinking water for six weeks to induce hyperoxaluria." | 8.31 | The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria. ( Abdel-Gabbar, M; Abdelaziz, MA; Abdelzaher, MH; Ahmed, OM; Geddawy, AI; Ibrahim, SR; Moawd, SA; Mohammad, MR; Mohideen, AP, 2023) |
| "Dietary intakes of 186 calcium oxalate stone formers, 93 with hyperoxaluria (>or=0." | 7.72 | Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. ( Ebert, D; Hesse, A; Nicolay, C; Siener, R, 2003) |
| "Daphnetin considerably suppress the renal, urine parameters." | 5.72 | Nephro-protective effect of Daphnetin in hyperoxaluria-induced rat renal injury via alterations of the gut microbiota. ( Gong, X; Wen, W; Zhang, W; Zhao, Y; Zhou, R, 2022) |
| "A critical appraisal of the evidence commonly cited to support a link between high urate excretion and calcium oxalate (CaOx) urinary calculi is presented." | 4.79 | Urate and calcium oxalate stones: from repute to rhetoric to reality. ( Grover, PK; Ryall, RL, 1994) |
| "75 percent ethylene glycol (v/v) in their drinking water for six weeks to induce hyperoxaluria." | 4.31 | The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria. ( Abdel-Gabbar, M; Abdelaziz, MA; Abdelzaher, MH; Ahmed, OM; Geddawy, AI; Ibrahim, SR; Moawd, SA; Mohammad, MR; Mohideen, AP, 2023) |
| " Metabolic abnormalities were significantly more present in patients with mixed infected stones (struvite+/-apatite and calcium oxalate) than in patients with pure infected stones (struvite+/-carbonate apatite): hypercalciuria in 40%, hyperoxaluria in 34% and hyperuricosuria in 28% (p < 0." | 3.83 | Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary? ( Cicerello, E; Cova, GD; Maccatrozzo, L; Mangano, M; Merlo, F, 2016) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| " In our study, calcium and uric acid abnormalities were the most common, and vesicoureteral reflux seemed to be the most common urological abnormality which led to urinary stasis and calculus formation." | 3.76 | Metabolic factors associated with urinary calculi in children. ( Alamdaran, SA; Naseri, M; Varasteh, AR, 2010) |
| "5), hypercalciuria-calcium greater than 200 mg, hyperoxaluria-oxalate greater than 45 mg, hyperuricosuria-uric acid greater than 600 mg, hypocitraturia-citrate less than 600 mg and purine gluttony-sulfate greater than 20 mg." | 3.73 | Ethnic background has minimal impact on the etiology of nephrolithiasis. ( Ekeruo, WO; Enemchukwu, CU; Maloney, ME; Preminger, GM; Springhart, WP; Young, MD, 2005) |
| "Dietary intakes of 186 calcium oxalate stone formers, 93 with hyperoxaluria (>or=0." | 3.72 | Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. ( Ebert, D; Hesse, A; Nicolay, C; Siener, R, 2003) |
| "Kidney stones are associated with various biochemical disturbances in urine." | 2.44 | Pharmacotherapy of kidney stones. ( Pak, CY, 2008) |
| "Daphnetin considerably suppress the renal, urine parameters." | 1.72 | Nephro-protective effect of Daphnetin in hyperoxaluria-induced rat renal injury via alterations of the gut microbiota. ( Gong, X; Wen, W; Zhang, W; Zhao, Y; Zhou, R, 2022) |
| "Hyperoxaluria was seen in 93 (40." | 1.48 | Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran. ( Ghorbani, F; Hadian, B; Zafar-Mohtashami, A, 2018) |
| "Prevalence of urinary calculi in children has been increasing in the past years." | 1.46 | Fourier Transform Infrared Analysis of Urinary Calculi and Metabolic Studies in a Group of Sicilian Children. ( D'Alessandro, MM; Gennaro, G; Maringhini, S; Tralongo, P, 2017) |
| " Metabolic study consisted of two 24-h urine collections separated by a period of 3 months for dosing Ca, P, uric acid, Na, K, Mg, oxalate, and citrate." | 1.42 | An update on metabolic assessment in patients with urinary lithiasis. ( Amaro, CR; Amaro, JL; Damasio, PC; Goldberg, J; Leitão, VA; Padovani, CR; Turney, B, 2015) |
| "Hypercalciuria, hypocitraturia, hyperoxaluria, hyperuricosuria, and cystinuria were detected in 41%, 39%, 22%, 9%, and 4% of the patients, respectively." | 1.42 | Metabolic disorders in Turkish children with urolithiasis. ( Aydogan, G; Celiksoy, MH; Kiyak, A; Sander, S; Topal, E; Yilmaz, A, 2015) |
| "Urinary tract infections (UTIs) were detected in 65." | 1.39 | Urinary stone disease in the first year of life: is it dangerous? ( Alpay, H; Bıyıklı, N; Gokce, I; Özen, A, 2013) |
| "Hyperoxaluria, hypernatruria, and hypercalciuria were found in 84 (77%), 43 (39." | 1.39 | Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. ( Aksakal, N; Bozkırlı, I; Gülbahar, O; Irkilata, L; Karaoğlan, U; Kıraç, M; Küpeli, B, 2013) |
| "Among those who do, recurrence is common, and metabolic profile and composition are varied as in the general stone-forming population." | 1.38 | Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. ( Gettman, MT; Krambeck, AE; McPhail, EF; Patterson, DE; Rangel, LJ, 2012) |
| "Hypocitraturia and hyperoxaluria (P=0." | 1.38 | Response to dietary oxalate after bariatric surgery. ( Arasaki, CH; Baxmann, AC; Froeder, L; Heilberg, IP; Malheiros, CA, 2012) |
| "Urolithiasis is one of the commonest problems in pediatric nephrology." | 1.36 | Clinical manifestations and etiology of renal stones in children less than 14 years age. ( Heidari, A; Sepahi, MA; Shajari, A, 2010) |
| "Primary distal renal tubular acidosis (dRTA) is an inherited disease characterized by the inability of the distal tubule to lower urine pH <5." | 1.35 | Atypical presentation of distal renal tubular acidosis in two siblings. ( Blau, N; Cheong, HI; Gucev, Z; Hoppe, B; Korneti, P; Tasic, V, 2008) |
| "Hyperuricosuria, hyperoxaluria and a low urinary volume did not influence the risk for active stone formation." | 1.33 | Risk factors determining active urinary stone formation in patients with urolithiasis. ( Netelenbos, JC; ter Wee, PM; Zwijnenburg, PJ, 2005) |
| "All patients with symptomatic calyceal diverticular stones who had comprehensive metabolic evaluation had metabolic abnormalities." | 1.33 | Metabolic abnormalities associated with calyceal diverticular stones. ( Auge, BK; Maloney, ME; Mathias, BJ; Pietrow, PK; Preminger, GM, 2006) |
| "Treatment with lupeol and lupeol linoleate reduced the extent of tubular damage as evidenced from reduced enzymuria and minimized the excretion of stone forming constituents." | 1.31 | Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats. ( Lenin, M; Varalakshmi, P; Vidya, L, 2002) |
| "The frequency of hyperoxaluria did not differ between cases and controls, but was three times more common among men compared with women." | 1.31 | Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. ( Curhan, GC; Speizer, FE; Stampfer, MJ; Willett, WC, 2001) |
| "Hyperoxaluria was induced by feeding 1% ethylene glycol to rats." | 1.31 | Effect of hyperoxaluria on the inhibitory activity of a 45-kD urinary protein. ( Balakrishnan, S; Kalaiselvi, P; Selvam, R, 2002) |
| "Hyperuraturia and hyperoxaluria occurred in the treatment with immunosuppressants, diuretics and correlated with the impairment of other tubular functions of the kidneys." | 1.28 | [Urinary excretion of oxalates and urates in a nephrotic form of glomerulonephritis in children]. ( Kutafina, EK; Sergeeva, TV; Sil'vestrova, LA, 1991) |
| "The latter ones involved oxaluria (28 children), uraturia (17 children), cystinuria (14 children), and phosphaturia (9 children)." | 1.28 | [Use of xidifon for prevention and treatment of nephropathies with metabolic disorders in children]. ( Dunaeva, IP; Gavriushova, LP; Iur'eva, EA; Korovina, NA; Kulakova, GI; Mumladze, EB; Rzhevskaia, ON; Tvorogova, TM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (7.35) | 18.7374 |
| 1990's | 15 (22.06) | 18.2507 |
| 2000's | 18 (26.47) | 29.6817 |
| 2010's | 26 (38.24) | 24.3611 |
| 2020's | 4 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, R | 1 |
| Wen, W | 1 |
| Gong, X | 1 |
| Zhao, Y | 1 |
| Zhang, W | 1 |
| Abdelaziz, MA | 1 |
| Ahmed, OM | 1 |
| Abdel-Gabbar, M | 1 |
| Mohammad, MR | 1 |
| Ibrahim, SR | 1 |
| Abdelzaher, MH | 1 |
| Mohideen, AP | 1 |
| Moawd, SA | 1 |
| Geddawy, AI | 1 |
| Huynh, LM | 1 |
| Dianatnejad, S | 1 |
| Tofani, S | 1 |
| Carrillo Ceja, R | 1 |
| Liang, K | 1 |
| Tapiero, S | 1 |
| Jiang, P | 1 |
| Youssef, RF | 1 |
| Brinkman, JE | 1 |
| Large, T | 1 |
| Nottingham, CU | 1 |
| Stoughton, C | 1 |
| Krambeck, AE | 2 |
| D'Alessandro, MM | 1 |
| Gennaro, G | 1 |
| Tralongo, P | 1 |
| Maringhini, S | 1 |
| Guillén, R | 1 |
| Ramos, C | 1 |
| Ayala, R | 1 |
| Funes, P | 1 |
| Ruiz, I | 1 |
| Zenteno, J | 1 |
| Sosa, L | 1 |
| Echague, G | 1 |
| Otto, BJ | 1 |
| Bozorgmehri, S | 1 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 1 |
| Canales, B | 1 |
| Hadian, B | 1 |
| Zafar-Mohtashami, A | 1 |
| Ghorbani, F | 1 |
| Khan, A | 1 |
| Kohjimoto, Y | 1 |
| Sasaki, Y | 1 |
| Iguchi, M | 1 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 1 |
| Cunha, NB | 1 |
| Kawano, PR | 1 |
| Padovani, CR | 2 |
| Lima, Fde O | 1 |
| Bernardes, S | 1 |
| Magalhães, ES | 1 |
| Amaro, CR | 2 |
| Amaro, JL | 2 |
| Wu, W | 1 |
| Yang, D | 1 |
| Tiselius, HG | 1 |
| Ou, L | 1 |
| Liang, Y | 1 |
| Zhu, H | 1 |
| Li, S | 1 |
| Zeng, G | 1 |
| Goldberg, J | 1 |
| Damasio, PC | 1 |
| Leitão, VA | 1 |
| Turney, B | 1 |
| Ferraro, PM | 1 |
| Robertson, WG | 1 |
| Johri, N | 1 |
| Nair, A | 1 |
| Gambaro, G | 1 |
| Shavit, L | 1 |
| Moochhala, SH | 1 |
| Unwin, RJ | 1 |
| Celiksoy, MH | 1 |
| Yilmaz, A | 1 |
| Aydogan, G | 1 |
| Kiyak, A | 1 |
| Topal, E | 1 |
| Sander, S | 1 |
| Arrabal-Polo, MA | 2 |
| Cano-Garcia, Mdel C | 1 |
| Arrabal-Martin, M | 2 |
| Lee, ST | 1 |
| Cho, H | 1 |
| Pfau, A | 1 |
| Knauf, F | 1 |
| Cicerello, E | 1 |
| Mangano, M | 1 |
| Cova, GD | 1 |
| Merlo, F | 1 |
| Maccatrozzo, L | 1 |
| Cano-García, MC | 1 |
| Domínguez-Amillo, A | 1 |
| Canales-Casco, N | 1 |
| de la Torre-Trillo, J | 1 |
| Cózar-Olmo, JM | 1 |
| Pak, CY | 1 |
| Tanaka, ST | 1 |
| Pope, JC | 1 |
| Alpay, H | 2 |
| Ozen, A | 2 |
| Gokce, I | 2 |
| Biyikli, N | 2 |
| Sepahi, MA | 1 |
| Heidari, A | 1 |
| Shajari, A | 1 |
| Naseri, M | 1 |
| Varasteh, AR | 1 |
| Alamdaran, SA | 1 |
| Gürgöze, MK | 1 |
| Sarı, MY | 1 |
| McPhail, EF | 1 |
| Gettman, MT | 1 |
| Patterson, DE | 1 |
| Rangel, LJ | 1 |
| McMahon, GM | 1 |
| Seifter, JL | 1 |
| Eisner, BH | 1 |
| Sheth, S | 1 |
| Dretler, SP | 2 |
| Herrick, B | 1 |
| Pais, VM | 1 |
| Akl, K | 1 |
| Ghawanmeh, R | 1 |
| Froeder, L | 1 |
| Arasaki, CH | 1 |
| Malheiros, CA | 1 |
| Baxmann, AC | 1 |
| Heilberg, IP | 1 |
| Kıraç, M | 1 |
| Küpeli, B | 1 |
| Irkilata, L | 1 |
| Gülbahar, O | 1 |
| Aksakal, N | 1 |
| Karaoğlan, U | 1 |
| Bozkırlı, I | 1 |
| Vidya, L | 1 |
| Lenin, M | 1 |
| Varalakshmi, P | 1 |
| Siener, R | 1 |
| Ebert, D | 1 |
| Nicolay, C | 1 |
| Hesse, A | 1 |
| Parmar, MS | 1 |
| Netelenbos, JC | 1 |
| Zwijnenburg, PJ | 1 |
| ter Wee, PM | 1 |
| Maloney, ME | 2 |
| Springhart, WP | 1 |
| Ekeruo, WO | 1 |
| Young, MD | 1 |
| Enemchukwu, CU | 1 |
| Preminger, GM | 3 |
| Auge, BK | 1 |
| Mathias, BJ | 1 |
| Pietrow, PK | 1 |
| Nicoletta, JA | 1 |
| Lande, MB | 1 |
| Vella, M | 1 |
| Karydi, M | 1 |
| Coraci, G | 1 |
| Oriti, R | 1 |
| Melloni, D | 1 |
| Spivacow, FR | 1 |
| Negri, AL | 1 |
| del Valle, EE | 1 |
| Calviño, I | 1 |
| Fradinger, E | 1 |
| Zanchetta, JR | 1 |
| Tasic, V | 1 |
| Korneti, P | 1 |
| Gucev, Z | 1 |
| Hoppe, B | 1 |
| Blau, N | 1 |
| Cheong, HI | 1 |
| Worcester, EM | 1 |
| Coe, FL | 1 |
| Grover, PK | 1 |
| Ryall, RL | 1 |
| Tomino, Y | 1 |
| Mizoguchi, M | 1 |
| Fuss, M | 1 |
| Cohen, TD | 1 |
| Ehreth, J | 1 |
| King, LR | 1 |
| Campoy Martínez, P | 1 |
| Reina Ruiz, C | 1 |
| Salazar Murillo, R | 1 |
| Quintero Rodríguez, R | 1 |
| Espinosa Olmedo, FJ | 1 |
| García Pérez, M | 1 |
| Schenkman, NS | 1 |
| Stoller, ML | 1 |
| Bataille, P | 1 |
| Pruna, A | 1 |
| Hottelart, C | 1 |
| Ghazali, A | 1 |
| Oprisiu, R | 1 |
| Rumpala, C | 1 |
| Hardy, P | 1 |
| Achard, JM | 1 |
| Fournier, A | 1 |
| Thomas, SE | 1 |
| Stapleton, FB | 1 |
| Curhan, GC | 1 |
| Willett, WC | 1 |
| Speizer, FE | 1 |
| Stampfer, MJ | 1 |
| Goldfarb, DS | 1 |
| Asplin, JR | 1 |
| Selvam, R | 1 |
| Balakrishnan, S | 1 |
| Kalaiselvi, P | 1 |
| Radermacher, L | 1 |
| Godon, JP | 1 |
| De Santo, NG | 1 |
| Di Iorio, B | 1 |
| Capasso, G | 1 |
| Paduano, C | 1 |
| Stamler, R | 1 |
| Langman, CB | 1 |
| Stamler, J | 1 |
| Sil'vestrova, LA | 1 |
| Sergeeva, TV | 1 |
| Kutafina, EK | 1 |
| Smith, LH | 2 |
| LaPorte, J | 1 |
| Baum, N | 1 |
| Korovina, NA | 1 |
| Gavriushova, LP | 1 |
| Iur'eva, EA | 1 |
| Rzhevskaia, ON | 1 |
| Mumladze, EB | 1 |
| Tvorogova, TM | 1 |
| Kulakova, GI | 1 |
| Dunaeva, IP | 1 |
| Paillard, M | 1 |
| Polinsky, MS | 1 |
| Kaiser, BA | 1 |
| Baluarte, HJ | 1 |
| Graziani, G | 1 |
| Aroldi, A | 1 |
| Castelnovo, C | 1 |
| Scalamogna, A | 1 |
| Surian, M | 2 |
| Malberti, F | 2 |
| Colussi, G | 2 |
| De Ferrari, ME | 2 |
| Rombolà, G | 2 |
| Benazzi, E | 2 |
| Minetti, L | 2 |
| Brenna, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Investigation of Aging Men With Renal Stones: The Role of Bone Demineralization (Metabolic and Hormonal Assessment)[NCT01246531] | 42 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| Variation in Urine Electrolytes, pH and Specific Gravity Throughout the Day and the Effect of Increased Fluid Intake on Intra-Day Urine Composition[NCT03645785] | 23 participants (Actual) | Interventional | 2018-08-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Ca/Cr at 4 voids throughout the day. Pre = baseline fluid intake; Post = increased fluid and citrate supplementation (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | Ratio (Mean) |
|---|---|
| 5pm Void Post | 0.162234 |
| 5p.m. Pre | 0.161287 |
| 1-2 pm Post | 0.137398 |
| 1-2pm Void Pre | 0.140431 |
| 9-10AM Post | 0.126269 |
| 9-10AM Pre | 0.111446 |
| First Void Pre | 0.160932 |
| First Void Post | 0.142987 |
Citrate/Cr at 4 voids throughout the day. Pre = baseline fluid intake; Post = increased fluid and citrate supplementation (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | ratio (Mean) |
|---|---|
| 5pm Void Post | 0.658644 |
| 5p.m. Pre | 0.584115 |
| 1-2 pm Post | 0.562886 |
| 1-2pm Void Pre | 0.540394 |
| 9-10AM Post | 0.490685 |
| 9-10AM Pre | 0.441938 |
| First Void Pre | 0.423415 |
| First Void Post | 0.404892 |
pH at 4 voids throughout the day. Pre = baseline fluid intake; Post (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | pH (Mean) |
|---|---|
| 5pm Void Post | 6.52770 |
| 5p.m. Pre | 6.32645 |
| 1-2 pm Post | 6.34060 |
| 1-2pm Void Pre | 6.37845 |
| 9-10AM Post | 6.43430 |
| 9-10AM Pre | 6.24125 |
| First Void Pre | 6.08345 |
| First Void Post | 6.01865 |
SG at 4 voids throughout the day. Pre = baseline fluid intake; Post (NCT03645785)
Timeframe: Day 1 (first void, 9-10 am, 1-2 pm and 5 pm) and Day 4 (first void, 9-10 am, 1-2 pm and 5 pm)
| Intervention | g/mL (Mean) |
|---|---|
| 5pm Void Post | 1.01725 |
| 5p.m. Pre | 1.01525 |
| 1-2 pm Post | 1.01725 |
| 1-2pm Void Pre | 1.01850 |
| 9-10AM Post | 1.01950 |
| 9-10AM Pre | 1.02051 |
| First Void Pre | 1.02000 |
| First Void Post | 1.01825 |
(NCT03645785)
Timeframe: Over 4 day study period
| Intervention | mL (Mean) |
|---|---|
| Day 1 | 2416.854 |
| Day 2 | 2625.093 |
| Day 3 | 3116.562 |
| Day 4 | 3396.781 |
23 reviews available for uric acid and Hyperoxaluria
| Article | Year |
|---|---|
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Topics: Citric Acid; Female; Global Health; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Met | 2020 |
Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.
Topics: Alpha-Globulins; Animals; Calcium-Binding Proteins; Citric Acid; Extracellular Matrix Proteins; Hepa | 2018 |
[Etiopathogenic factors of the different types of urinary litiasis.]
Topics: Algorithms; Calcium; Humans; Hyperoxaluria; Kidney Calculi; Uric Acid; Urolithiasis | 2017 |
Pharmacotherapy of kidney stones.
Topics: Animals; Citric Acid; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Secondary Prevention; U | 2008 |
Pediatric stone disease.
Topics: Animals; Child; Comorbidity; Diagnostic Imaging; Humans; Hyperoxaluria; Length of Stay; Lithotripsy; | 2009 |
Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
Topics: Citric Acid; Diet; Humans; Hydrogen-Ion Concentration; Hypercalciuria; Hyperoxaluria; Nephrolithiasi | 2012 |
Kidney stones.
Topics: Calcium; Citric Acid; Colic; Glycoproteins; Humans; Hyperoxaluria; Kidney Calculi; Magnesium Compoun | 2004 |
Medical evaluation and treatment of urolithiasis.
Topics: Adolescent; Calcium Metabolism Disorders; Child; Child, Preschool; Cystinuria; Humans; Hyperoxaluria | 2006 |
Pathophysiology and clinical aspects of urinary lithiasis.
Topics: Calcium; Cystine; Cystinuria; Drug-Related Side Effects and Adverse Reactions; Humans; Hypercalciuri | 2007 |
Nephrolithiasis.
Topics: Acute Disease; Humans; Hypercalciuria; Hyperoxaluria; Hyperparathyroidism; Nephrolithiasis; Risk Fac | 2008 |
Urate and calcium oxalate stones: from repute to rhetoric to reality.
Topics: Allopurinol; Calcium Oxalate; Glycosaminoglycans; Gout; Humans; Hydrogen-Ion Concentration; Hyperoxa | 1994 |
[Kidney diseases caused by hypercalcemia, hyperuricemia, hyperoxaluria and hypokalemia].
Topics: Humans; Hypercalcemia; Hyperoxaluria; Hypokalemia; Kidney; Kidney Diseases; Uric Acid | 1994 |
[Metabolic aspects of renal calcium calculi].
Topics: Calcium; Calcium Oxalate; Calcium Phosphates; Citrates; Humans; Hydrogen-Ion Concentration; Hyperoxa | 1994 |
Pediatric urolithiasis: medical and surgical management.
Topics: Calcium; Child; Citrates; Cystine; Humans; Hyperoxaluria; Lithotripsy; Nephrostomy, Percutaneous; Ur | 1996 |
[Idiopathic calcium lithiasis. Dietary correction of metabolic risk factors. Physiopathological bases].
Topics: Calcium, Dietary; Citrates; Diet, Protein-Restricted; Female; Humans; Hypercalcemia; Hyperoxaluria; | 1998 |
The physiologic approach to the medical management of stone disease.
Topics: Acetazolamide; Calcium; Carbonic Anhydrase Inhibitors; Citrates; Cystinuria; Humans; Hyperoxaluria; | 1998 |
Leave no "stone" unturned: understanding the genetic bases of calcium-containing urinary stones in children.
Topics: Adult; Age Factors; Calcium; Calcium Oxalate; Child; Cystinuria; Diagnosis, Differential; Diet; Huma | 2000 |
[Preventive medical treatment of kidney stones].
Topics: Calcium; Citrates; Cystine; Diet; Drinking; Humans; Hyperoxaluria; Kidney Calculi; Phosphates; Purin | 1992 |
Idiopathic calcium oxalate urolithiasis.
Topics: Calcium; Humans; Hydrogen-Ion Concentration; Hyperoxaluria; Uric Acid; Urinary Calculi; Urine | 1990 |
Kidney stones. How to identify the cause and prevent recurrence.
Topics: Calcium; Citrates; Humans; Hyperoxaluria; Kidney Calculi; Recurrence; Uric Acid | 1990 |
The pathophysiology and medical treatment of urolithiasis.
Topics: Acidosis, Renal Tubular; Calcium Oxalate; Crystallization; Cystinuria; Humans; Hypercalcemia; Hypero | 1990 |
Urolithiasis in childhood.
Topics: Acidosis, Renal Tubular; Adult; Calcium; Child; Child, Preschool; Diet; Female; Humans; Hyperoxaluri | 1987 |
Pathophysiological aspects of stone disease.
Topics: Calcium; Diet; Humans; Hyperoxaluria; Uric Acid; Urinary Calculi | 1987 |
2 trials available for uric acid and Hyperoxaluria
| Article | Year |
|---|---|
Results of medical treatment and metabolic risk factors in children with urolithiasis.
Topics: Adolescent; Calcium Metabolism Disorders; Child; Child, Preschool; Citric Acid; Cystinuria; Female; | 2011 |
Effect of grapefruit juice on urinary lithogenicity.
Topics: Adult; Beverages; Calcium Oxalate; Calcium Phosphates; Citrus; Female; Humans; Hyperoxaluria; Male; | 2001 |
43 other studies available for uric acid and Hyperoxaluria
| Article | Year |
|---|---|
Nephro-protective effect of Daphnetin in hyperoxaluria-induced rat renal injury via alterations of the gut microbiota.
Topics: Animals; Cytokines; Ethylene Glycols; Gastrointestinal Microbiome; Glutathione; Hyperoxaluria; Kidne | 2022 |
The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria.
Topics: Animals; Antioxidants; Atorvastatin; Body Weight; Creatinine; Ethylene Glycol; Humans; Hyperoxaluria | 2023 |
Clinical and Metabolic Correlates of Pure Stone Subtypes.
Topics: Calcium Oxalate; Female; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Retrospective | 2021 |
Fourier Transform Infrared Analysis of Urinary Calculi and Metabolic Studies in a Group of Sicilian Children.
Topics: Adolescent; Biomarkers; Calcium Oxalate; Calcium Phosphates; Child; Child, Preschool; Female; Humans | 2017 |
[Lithogenic risk index in urinary lithiasis patients and their evolution after treatment.]
Topics: Calcium; Calcium Oxalate; Female; Humans; Hypercalciuria; Hyperoxaluria; Male; Risk Factors; Uric Ac | 2017 |
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
Topics: Adult; Biomarkers; Calcium; Citrates; Cross-Sectional Studies; Female; Humans; Hypercalciuria; Hyper | 2018 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
Nephrocalcinosis induced by hyperoxaluria in rats.
Topics: Animals; Calcium; Citric Acid; Hyperoxaluria; Kidney; Male; Nephrocalcinosis; Oxalates; Random Alloc | 2013 |
The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Topics: Adult; Calcium Oxalate; Calcium Phosphates; China; Citric Acid; Cystine; Female; Humans; Hypercalciu | 2014 |
An update on metabolic assessment in patients with urinary lithiasis.
Topics: Adult; Citric Acid; Creatinine; Female; Humans; Hypercalciuria; Hyperoxaluria; Magnesium; Male; Prev | 2015 |
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Cohort Studies; Cross-Sectional Studies; Di | 2015 |
Metabolic disorders in Turkish children with urolithiasis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalc | 2015 |
Lithogenic activity as a factor to consider in the metabolic evaluation of patients with calcium lithiasis.
Topics: Adult; Calcium; Chlorides; Citrates; Creatinine; Fasting; Female; Humans; Hypercalciuria; Hyperoxalu | 2015 |
Metabolic features and renal outcomes of urolithiasis in children.
Topics: Adolescent; Child; Child, Preschool; Cystinuria; Female; Humans; Hypercalciuria; Hyperoxaluria; Infa | 2016 |
Update on Nephrolithiasis: Core Curriculum 2016.
Topics: Acidosis, Renal Tubular; Calcium Phosphates; Curriculum; Cystinuria; Diet; Humans; Hyperoxaluria; Ne | 2016 |
Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Topics: Adolescent; Adult; Aged; Apatites; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; | 2016 |
Clinical and metabolic features of urolithiasis and microlithiasis in children.
Topics: Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuria; Hyperoxal | 2009 |
Clinical manifestations and etiology of renal stones in children less than 14 years age.
Topics: Adolescent; Child; Child, Preschool; Citric Acid; Cystinuria; Dysuria; Female; Fever; Genetic Predis | 2010 |
Metabolic factors associated with urinary calculi in children.
Topics: Adolescent; Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuri | 2010 |
Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Diuresis; Female; Humans; Hypercalciuria; H | 2012 |
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Topics: Adult; Aged; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Linear Models; Male; Middle | 2012 |
The clinical spectrum of idiopathic hyperuricosuria in children: isolated and associated with hypercalciuria/hyperoxaluria.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Female; Humans; Hypercalciuria; Hyperoxaluria; Infa | 2012 |
Response to dietary oxalate after bariatric surgery.
Topics: Adult; Analysis of Variance; Bariatric Surgery; Calcium; Chi-Square Distribution; Citrates; Creatini | 2012 |
Urinary stone disease in the first year of life: is it dangerous?
Topics: Cholelithiasis; Citrates; Cystic Fibrosis; Cystinuria; Epilepsy; Female; Genetic Predisposition to D | 2013 |
Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Diet; Female; Humans; Hypercalciuria; Hyperoxaluria; K | 2013 |
Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats.
Topics: Acetylglucosaminidase; Alkaline Phosphatase; Animals; Calcium; Calcium Oxalate; gamma-Glutamyltransf | 2002 |
Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
Topics: Adult; Calcium; Calcium Oxalate; Case-Control Studies; Female; Follow-Up Studies; Humans; Hyperoxalu | 2003 |
Risk factors determining active urinary stone formation in patients with urolithiasis.
Topics: Adult; Calcium; Citric Acid; Female; Humans; Hyperoxaluria; Male; Middle Aged; Recurrence; Retrospec | 2005 |
Ethnic background has minimal impact on the etiology of nephrolithiasis.
Topics: Adult; Aged; Calcium; Citric Acid; Cross-Sectional Studies; Ethnicity; Female; Gout; Humans; Hyperox | 2005 |
Metabolic abnormalities associated with calyceal diverticular stones.
Topics: Adult; Calcium; Diverticulum; Female; Humans; Hyperoxaluria; Kidney Calculi; Male; Middle Aged; Recu | 2006 |
Metabolic risk factors in children with kidney stone disease.
Topics: Abdominal Pain; Adolescent; Argentina; Child; Child, Preschool; Citrates; Female; Genetic Predisposi | 2008 |
Atypical presentation of distal renal tubular acidosis in two siblings.
Topics: Acidosis, Renal Tubular; Child, Preschool; Chlorides; Growth Disorders; Hearing Loss, Sensorineural; | 2008 |
[A metabolic study of urolithiasis. Specificity, sensitivity, efficacy and reproducibility].
Topics: Absorption; Adolescent; Adult; Aged; Calcium; Citrates; Citric Acid; Clinical Protocols; Creatinine; | 1995 |
Urolithiasis.
Topics: Calcium; Citric Acid; Humans; Hyperoxaluria; Recurrence; Uric Acid; Urinary Calculi | 1998 |
Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
Topics: Adult; Calcium; Citric Acid; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperoxaluria; Kidne | 2001 |
Effect of hyperoxaluria on the inhibitory activity of a 45-kD urinary protein.
Topics: Animals; Calcium; Calcium Oxalate; Crystallization; Hyperoxaluria; Magnesium; Male; Molecular Weight | 2002 |
Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy).
Topics: Adolescent; Calcium; Child; Child, Preschool; Electrolytes; Female; Humans; Hyperoxaluria; Italy; Ma | 1992 |
[Urinary excretion of oxalates and urates in a nephrotic form of glomerulonephritis in children].
Topics: Adolescent; Child; Child, Preschool; Circadian Rhythm; Diuretics; Humans; Hyperoxaluria; Nephrosis, | 1991 |
[Use of xidifon for prevention and treatment of nephropathies with metabolic disorders in children].
Topics: Adolescent; Calcium Metabolism Disorders; Child; Child, Preschool; Cystinuria; Diphosphonates; Etidr | 1990 |
[Metabolic investigation of calcium renal lithiasis in adults and therapeutic advice].
Topics: Calcium; Calcium, Dietary; Citrates; Humans; Hyperoxaluria; Kidney Calculi; Risk Factors; Uric Acid | 1989 |
Medical treatment of idiopathic calcium nephrolithiasis.
Topics: Allopurinol; Amiloride; Calcium; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperoxalur | 1987 |
Calcium nephrolithiasis and renal tubular hypouricemia.
Topics: Adult; Calcium; Female; Humans; Hyperoxaluria; Kidney Calculi; Kidney Diseases; Kidney Tubules; Midd | 1987 |